Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
360.00    0.00 (0.00%)
Bid:
354.50
Ask:
360.00
Spread: 5.50 (1.551%)
Market Cap: £1.84b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

2023 AGM results update statement

19 Jan 2024 16:30

RNS Number : 3461A
Caledonia Investments PLC
19 January 2024

Caledonia Investments plc

2023 annual general meeting ("AGM") results update statement

In accordance with Provision 4 of the UK Corporate Governance Code, Caledonia Investments plc (the "Company") provides an update on the feedback received and any actions the Company intends to take following the outcome of voting in respect of resolution 19 at the 2023 AGM.

Resolution 19 was the waiver of the mandatory offer provisions set out in Rule 9 of The City Code on Takeovers and Mergers in relation to the Cayzer family concert party, given the obligation that could arise on the concert party to make a general offer for the entire issued share capital of the Company as a result of purchases by the Company of ordinary shares pursuant to the authority received from shareholders to make market purchases.

Resolution 19 passed with a majority of votes cast by independent shareholders in favour. However, more than 20% of participating independent shareholders voted against. This included one large shareholder who, having previously supported the resolution, recently adopted a policy of voting in line with the voting recommendations of a proxy voting advisor which is generally not supportive of such Rule 9 waiver resolutions given their potential to lead to creeping control. In response to the feedback received from this shareholder, who continues to be supportive of management, the Company continues to engage with this proxy voting advisor.

The Company is grateful to all those that have taken the time to engage on this issue. We recognise the concern raised by the proxy voting advisor. However, the directors believe that the Company's ability to exercise the authority to make market purchases of its own shares warranted approval of the Rule 9 waiver resolution.

19 January 2024

For further information please contact:

Company contacts

Caledonia Investments plc

+44 20 7802 8080

David Stewart

Chairman

Media contacts

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

caledonia@teneo.com

END

Notes for editors:

Caledonia Investments plc

Caledonia is a self-managed investment trust company. Our aim is to grow net assets and dividends paid to shareholders, whilst managing risk to avoid the permanent loss of capital. We achieve this by investing in proven, well-managed businesses that combine long term growth characteristics with an ability to deliver increasing levels of income. We hold investments in both listed and private markets, covering a range of sectors and, particularly through the listed and fund investments, have a global reach.

For additional information on Caledonia, please visit www.caledonia.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGMSFSFLUELSEIF
Date   Source Headline
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 202611:00 amRNSNet Asset Value(s)
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 202610:30 amRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSFunds spotlight event
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 202611:36 amRNSDirector/PDMR Shareholding
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 202611:00 amRNSAppointment of non-executive director
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:00 pmRNSDirector/PDMR Shareholding
12th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSNet Asset Value(s)
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20251:36 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 202511:00 amRNSNet Asset Value(s)
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
28th Nov 20255:04 pmRNSDirector/PDMR Shareholding
28th Nov 20252:51 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 202512:42 pmRNSIrrevocable Share Repurchase Instruction
25th Nov 20257:00 amRNSHalf-year Financial Report
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.